ID   AZIN2_HUMAN             Reviewed;         460 AA.
AC   Q96A70; B2RDU5; D3DPQ9; Q5TIF4; Q5TIF5; Q5TIF6; Q8TF56; Q96L54;
AC   Q96L55; Q96L56; Q96L57; Q96MD9;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   15-MAR-2017, entry version 140.
DE   RecName: Full=Antizyme inhibitor 2;
DE            Short=AzI2;
DE   AltName: Full=Arginine decarboxylase;
DE            Short=ADC;
DE            Short=ARGDC;
DE   AltName: Full=Ornithine decarboxylase-like protein;
DE            Short=ODC-like protein;
DE   AltName: Full=ornithine decarboxylase paralog;
DE            Short=ODC-p;
GN   Name=AZIN2; Synonyms=ADC, KIAA1945, ODCP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4 AND 6), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=11587527; DOI=10.1006/bbrc.2001.5703;
RA   Pitkaenen L.T., Heiskala M., Andersson L.C.;
RT   "Expression of a novel human ornithine decarboxylase-like protein in
RT   the central nervous system and testes.";
RL   Biochem. Biophys. Res. Commun. 287:1051-1057(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=14738999; DOI=10.1016/j.bbagen.2003.11.006;
RA   Zhu M.-Y., Iyo A., Piletz J.E., Regunathan S.;
RT   "Expression of human arginine decarboxylase, the biosynthetic enzyme
RT   for agmatine.";
RL   Biochim. Biophys. Acta 1670:156-164(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11853319; DOI=10.1093/dnares/8.6.319;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XXII.
RT   The complete sequences of 50 new cDNA clones which code for large
RT   proteins.";
RL   DNA Res. 8:319-327(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Substantia nigra, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, INTERACTION WITH OAZ1; OAZ2 AND OAZ3, AND UBIQUITINATION.
RX   PubMed=17900240; DOI=10.1042/BJ20071004;
RA   Kanerva K., Makitie L.T., Pelander A., Heiskala M., Andersson L.C.;
RT   "Human ornithine decarboxylase paralogue (ODCp) is an antizyme
RT   inhibitor but not an arginine decarboxylase.";
RL   Biochem. J. 409:187-192(2008).
RN   [9]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19756694; DOI=10.1007/s00418-009-0636-7;
RA   Makitie L.T., Kanerva K., Sankila A., Andersson L.C.;
RT   "High expression of antizyme inhibitor 2, an activator of ornithine
RT   decarboxylase in steroidogenic cells of human gonads.";
RL   Histochem. Cell Biol. 132:633-638(2009).
RN   [10]
RP   SUBCELLULAR LOCATION, INDUCTION, AND TISSUE SPECIFICITY.
RX   PubMed=19718454; DOI=10.1371/journal.pone.0006858;
RA   Kanerva K., Lappalainen J., Makitie L.T., Virolainen S., Kovanen P.T.,
RA   Andersson L.C.;
RT   "Expression of antizyme inhibitor 2 in mast cells and role of
RT   polyamines as selective regulators of serotonin secretion.";
RL   PLoS ONE 4:E6858-E6858(2009).
RN   [11]
RP   REVIEW, AND CHARACTERIZATION.
RX   PubMed=19956990; DOI=10.1007/s00726-009-0419-4;
RA   Lopez-Contreras A.J., Ramos-Molina B., Cremades A., Penafiel R.;
RT   "Antizyme inhibitor 2: molecular, cellular and physiological
RT   aspects.";
RL   Amino Acids 38:603-611(2010).
RN   [12]
RP   ALTERNATIVE SPLICING, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19832840; DOI=10.1111/j.1750-3639.2009.00334.x;
RA   Makitie L.T., Kanerva K., Polvikoski T., Paetau A., Andersson L.C.;
RT   "Brain neurons express ornithine decarboxylase-activating antizyme
RT   inhibitor 2 with accumulation in Alzheimer's disease.";
RL   Brain Pathol. 20:571-580(2010).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20188728; DOI=10.1016/j.yexcr.2010.02.021;
RA   Kanerva K., Makitie L.T., Back N., Andersson L.C.;
RT   "Ornithine decarboxylase antizyme inhibitor 2 regulates intracellular
RT   vesicle trafficking.";
RL   Exp. Cell Res. 316:1896-1906(2010).
CC   -!- FUNCTION: Antizyme inhibitor (AZI) protein that positively
CC       regulates ornithine decarboxylase (ODC) activity and polyamine
CC       uptake. AZI is an enzymatically inactive ODC homolog that
CC       counteracts the negative effect of ODC antizymes (AZs) OAZ1, OAZ2
CC       and OAZ3 on ODC activity by competing with ODC for antizyme-
CC       binding (PubMed:17900240). Inhibits antizyme-dependent ODC
CC       degradation and releases ODC monomers from their inactive complex
CC       with antizymes, leading to formation of the catalytically active
CC       ODC homodimer and restoring polyamine production
CC       (PubMed:17900240). Participates in the morphological integrity of
CC       the trans-Golgi network (TGN) and functions as a regulator of
CC       intracellular secretory vesicle trafficking (PubMed:20188728).
CC       {ECO:0000269|PubMed:17900240, ECO:0000269|PubMed:20188728}.
CC   -!- SUBUNIT: Monomer. Interacts with OAZ1, OAZ2 and OAZ3; this
CC       interaction disrupts the interaction between the antizyme and
CC       ODC1. Does not form a heterodimer with ODC1.
CC       {ECO:0000269|PubMed:17900240}.
CC   -!- INTERACTION:
CC       Q9UMX2:OAZ3; NbExp=5; IntAct=EBI-10281609, EBI-10281601;
CC       Q9UMX2-2:OAZ3; NbExp=4; IntAct=EBI-10281609, EBI-12049527;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm {ECO:0000250}. Cytoplasm,
CC       perinuclear region. Membrane {ECO:0000250}. Cytoplasmic vesicle.
CC       Endoplasmic reticulum-Golgi intermediate compartment
CC       {ECO:0000250}. Golgi apparatus, cis-Golgi network {ECO:0000250}.
CC       Golgi apparatus, trans-Golgi network. Cytoplasmic granule. Cell
CC       projection, axon. Cell projection, dendrite. Perikaryon.
CC       Note=Colocalizes with KDEL receptors in ER-Golgi intermediate
CC       compartment (ERGIC). Translocates from the ERGIC structure to the
CC       cytoplasm in an antizyme-dependent manner. Localizes with vesicle-
CC       associated membrane protein VAMP8 in the vicinity of the plasma
CC       membrane within serotonin-containing secretory granules (By
CC       similarity). Detected as vesicle-like pattern in neurite
CC       outgrowths. Localizes to the vesicular compartments of the
CC       secretory pathway, predominantly in the trans-Golgi network (TGN).
CC       Localizes with vesicle-associated membrane protein VAMP8 in the
CC       vicinity of the plasma membrane within serotonin-containing
CC       secretory granules. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q96A70-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96A70-2; Sequence=VSP_003756;
CC       Name=3;
CC         IsoId=Q96A70-3; Sequence=VSP_003757, VSP_003758;
CC       Name=4;
CC         IsoId=Q96A70-4; Sequence=VSP_003755, VSP_003757, VSP_003758;
CC       Name=6;
CC         IsoId=Q96A70-5; Sequence=VSP_003754, VSP_003757, VSP_003758;
CC   -!- TISSUE SPECIFICITY: Expressed in the neocortex, thalamus,
CC       hippocampus, cerebellum, medulla oblongata, gray and white matter.
CC       Expressed in neurons, oligodendrocytes, basket, Purkinje and
CC       pyramidal cells. Expressed in spermatocytes and Leydig cells of
CC       the testis. Expressed in luteal theca cells lining corpus luteum
CC       cysts and in hilus cells of the ovary. Expressed in primary and
CC       neoplastic mast cells (MC) (at protein level). Highly expressed in
CC       brain. Also expressed in testis. {ECO:0000269|PubMed:11587527,
CC       ECO:0000269|PubMed:14738999, ECO:0000269|PubMed:19718454,
CC       ECO:0000269|PubMed:19756694, ECO:0000269|PubMed:19832840}.
CC   -!- DOMAIN: The N-terminus domain is necessary for its localization to
CC       the ER-Golgi intermediate compartment (ERGIC). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated, leading to its proteosomal degradation; a
CC       process that is reduced in presence of antizymes. May also be
CC       degraded through the lysosomal degradative pathway in a
CC       proteosomal-independent manner. {ECO:0000269|PubMed:17900240}.
CC   -!- SIMILARITY: Belongs to the Orn/Lys/Arg decarboxylase class-II
CC       family. ODC antizyme inhibitor subfamily. {ECO:0000305}.
CC   -!- CAUTION: Was initially reported to have ornithine decarboxylase
CC       (PubMed:11587527) or arginine decarboxylase (PubMed:14738999)
CC       activities, but it was later found that the mouse ortholog does
CC       not possess either of them. {ECO:0000305|PubMed:11587527,
CC       ECO:0000305|PubMed:14738999}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY050634; AAL08049.1; -; mRNA.
DR   EMBL; AY050635; AAL08050.1; -; mRNA.
DR   EMBL; AY050636; AAL08051.1; -; mRNA.
DR   EMBL; AY050637; AAL08052.1; -; mRNA.
DR   EMBL; AY050638; AAL08053.1; -; mRNA.
DR   EMBL; AY325129; AAQ62560.1; -; mRNA.
DR   EMBL; AB075825; BAB85531.1; -; mRNA.
DR   EMBL; AK057051; BAB71356.1; -; mRNA.
DR   EMBL; AK095127; BAC04489.1; -; mRNA.
DR   EMBL; AK315677; BAG38042.1; -; mRNA.
DR   EMBL; AL020995; CAI19353.1; -; Genomic_DNA.
DR   EMBL; AL020995; CAI19354.1; -; Genomic_DNA.
DR   EMBL; AL020995; CAI19355.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07472.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07481.1; -; Genomic_DNA.
DR   EMBL; BC010449; AAH10449.1; -; mRNA.
DR   EMBL; BC028128; AAH28128.1; -; mRNA.
DR   CCDS; CCDS375.1; -. [Q96A70-1]
DR   CCDS; CCDS76138.1; -. [Q96A70-2]
DR   RefSeq; NP_001280491.1; NM_001293562.1. [Q96A70-1]
DR   RefSeq; NP_001288752.1; NM_001301823.1.
DR   RefSeq; NP_001288753.1; NM_001301824.1.
DR   RefSeq; NP_001288754.1; NM_001301825.1. [Q96A70-2]
DR   RefSeq; NP_001288755.1; NM_001301826.1. [Q96A70-3]
DR   RefSeq; NP_443724.1; NM_052998.3. [Q96A70-1]
DR   RefSeq; XP_005270461.1; XM_005270404.2. [Q96A70-1]
DR   RefSeq; XP_005270464.1; XM_005270407.1.
DR   RefSeq; XP_011538865.1; XM_011540563.1. [Q96A70-3]
DR   RefSeq; XP_016855657.1; XM_017000168.1.
DR   RefSeq; XP_016855658.1; XM_017000169.1.
DR   RefSeq; XP_016855659.1; XM_017000170.1.
DR   RefSeq; XP_016855660.1; XM_017000171.1.
DR   RefSeq; XP_016855661.1; XM_017000172.1.
DR   RefSeq; XP_016855662.1; XM_017000173.1.
DR   RefSeq; XP_016855664.1; XM_017000175.1.
DR   UniGene; Hs.101807; -.
DR   ProteinModelPortal; Q96A70; -.
DR   SMR; Q96A70; -.
DR   BioGrid; 125246; 10.
DR   IntAct; Q96A70; 1.
DR   STRING; 9606.ENSP00000294517; -.
DR   DrugBank; DB00125; L-Arginine.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   iPTMnet; Q96A70; -.
DR   PhosphoSitePlus; Q96A70; -.
DR   BioMuta; ADC; -.
DR   DMDM; 24636807; -.
DR   MaxQB; Q96A70; -.
DR   PaxDb; Q96A70; -.
DR   PeptideAtlas; Q96A70; -.
DR   PRIDE; Q96A70; -.
DR   DNASU; 113451; -.
DR   Ensembl; ENST00000294517; ENSP00000294517; ENSG00000142920. [Q96A70-1]
DR   Ensembl; ENST00000373440; ENSP00000362539; ENSG00000142920. [Q96A70-5]
DR   Ensembl; ENST00000373441; ENSP00000362540; ENSG00000142920. [Q96A70-2]
DR   Ensembl; ENST00000373443; ENSP00000362542; ENSG00000142920. [Q96A70-1]
DR   GeneID; 113451; -.
DR   KEGG; hsa:113451; -.
DR   UCSC; uc001bwr.3; human. [Q96A70-1]
DR   CTD; 113451; -.
DR   DisGeNET; 113451; -.
DR   GeneCards; AZIN2; -.
DR   HGNC; HGNC:29957; AZIN2.
DR   HPA; HPA028527; -.
DR   MIM; 608353; gene.
DR   neXtProt; NX_Q96A70; -.
DR   OpenTargets; ENSG00000142920; -.
DR   PharmGKB; PA142672642; -.
DR   eggNOG; KOG0622; Eukaryota.
DR   eggNOG; COG0019; LUCA.
DR   GeneTree; ENSGT00390000011560; -.
DR   HOVERGEN; HBG005456; -.
DR   InParanoid; Q96A70; -.
DR   KO; K01583; -.
DR   OMA; SHMEVVG; -.
DR   OrthoDB; EOG091G0AJV; -.
DR   PhylomeDB; Q96A70; -.
DR   TreeFam; TF300760; -.
DR   BioCyc; MetaCyc:HS06971-MONOMER; -.
DR   BRENDA; 4.1.1.17; 2681.
DR   BRENDA; 4.1.1.19; 2681.
DR   Reactome; R-HSA-351143; Agmatine biosynthesis.
DR   GeneWiki; ADC_(gene); -.
DR   GenomeRNAi; 113451; -.
DR   PRO; PR:Q96A70; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000142920; -.
DR   Genevisible; Q96A70; HS.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0005801; C:cis-Golgi network; ISS:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; ISS:UniProtKB.
DR   GO; GO:1990005; C:granular vesicle; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB.
DR   GO; GO:0030133; C:transport vesicle; IMP:UniProtKB.
DR   GO; GO:0008792; F:arginine decarboxylase activity; TAS:Reactome.
DR   GO; GO:0042978; F:ornithine decarboxylase activator activity; IDA:UniProtKB.
DR   GO; GO:0015489; F:putrescine transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0097055; P:agmatine biosynthetic process; TAS:Reactome.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; ISS:UniProtKB.
DR   GO; GO:1902269; P:positive regulation of polyamine transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0033387; P:putrescine biosynthetic process from ornithine; IBA:GO_Central.
DR   GO; GO:0015847; P:putrescine transport; ISS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; NAS:UniProtKB.
DR   GO; GO:0098629; P:trans-Golgi network membrane organization; IMP:UniProtKB.
DR   Gene3D; 2.40.37.10; -; 1.
DR   Gene3D; 3.20.20.10; -; 1.
DR   InterPro; IPR009006; Ala_racemase/Decarboxylase_C.
DR   InterPro; IPR031173; Azin2.
DR   InterPro; IPR022643; De-COase2_C.
DR   InterPro; IPR022657; De-COase2_CS.
DR   InterPro; IPR022644; De-COase2_N.
DR   InterPro; IPR022653; De-COase2_pyr-phos_BS.
DR   InterPro; IPR000183; Orn/DAP/Arg_de-COase.
DR   InterPro; IPR002433; Orn_de-COase.
DR   InterPro; IPR029066; PLP-binding_barrel.
DR   PANTHER; PTHR11482:SF55; PTHR11482:SF55; 1.
DR   Pfam; PF02784; Orn_Arg_deC_N; 1.
DR   Pfam; PF00278; Orn_DAP_Arg_deC; 1.
DR   PRINTS; PR01179; ODADCRBXLASE.
DR   PRINTS; PR01182; ORNDCRBXLASE.
DR   SUPFAM; SSF50621; SSF50621; 1.
DR   SUPFAM; SSF51419; SSF51419; 1.
DR   PROSITE; PS00878; ODR_DC_2_1; 1.
DR   PROSITE; PS00879; ODR_DC_2_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Golgi apparatus; Membrane; Nucleus;
KW   Polyamine biosynthesis; Polymorphism; Pyridoxal phosphate;
KW   Reference proteome; Transport; Ubl conjugation.
FT   CHAIN         1    460       Antizyme inhibitor 2.
FT                                /FTId=PRO_0000149944.
FT   REGION      117    140       Necessary for polyamine uptake
FT                                stimulation. {ECO:0000250}.
FT   SITE         70     70       Not modified.
FT                                {ECO:0000250|UniProtKB:O35484}.
FT   VAR_SEQ      94    251       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:11587527}.
FT                                /FTId=VSP_003754.
FT   VAR_SEQ     151    151       K -> KFVQQRGTACLIR (in isoform 4).
FT                                {ECO:0000303|PubMed:11587527}.
FT                                /FTId=VSP_003755.
FT   VAR_SEQ     305    305       E -> EAPLPPPHIATCAASEPSPPA (in isoform
FT                                2). {ECO:0000303|PubMed:11587527}.
FT                                /FTId=VSP_003756.
FT   VAR_SEQ     344    362       KPSTEQPLYSSSLWGPAVD -> SKNHSPCYMSLESIHFIA
FT                                V (in isoform 3, isoform 4 and isoform
FT                                6). {ECO:0000303|PubMed:11587527}.
FT                                /FTId=VSP_003757.
FT   VAR_SEQ     363    460       Missing (in isoform 3, isoform 4 and
FT                                isoform 6).
FT                                {ECO:0000303|PubMed:11587527}.
FT                                /FTId=VSP_003758.
FT   VARIANT     288    288       A -> S (in dbSNP:rs16835244).
FT                                /FTId=VAR_050611.
FT   CONFLICT      1     35       MAGYLSESDFVMVEEGFSTRDLLKELTLGASQATT -> QQ
FT                                GSSVASTEPGSGTWKDHGWHAQGASWMGSHIHPLLVIQ
FT                                (in Ref. 3; BAB85531). {ECO:0000305}.
SQ   SEQUENCE   460 AA;  49980 MW;  0E00667CA4BB0B56 CRC64;
     MAGYLSESDF VMVEEGFSTR DLLKELTLGA SQATTDEVAA FFVADLGAIV RKHFCFLKCL
     PRVRPFYAVK CNSSPGVLKV LAQLGLGFSC ANKAEMELVQ HIGIPASKII CANPCKQIAQ
     IKYAAKHGIQ LLSFDNEMEL AKVVKSHPSA KMVLCIATDD SHSLSCLSLK FGVSLKSCRH
     LLENAKKHHV EVVGVSFHIG SGCPDPQAYA QSIADARLVF EMGTELGHKM HVLDLGGGFP
     GTEGAKVRFE EIASVINSAL DLYFPEGCGV DIFAELGRYY VTSAFTVAVS IIAKKEVLLD
     QPGREEENGS TSKTIVYHLD EGVYGIFNSV LFDNICPTPI LQKKPSTEQP LYSSSLWGPA
     VDGCDCVAEG LWLPQLHVGD WLVFDNMGAY TVGMGSPFWG TQACHITYAM SRVAWEALRR
     QLMAAEQEDD VEGVCKPLSC GWEITDTLCV GPVFTPASIM
//
